{"id":6763,"date":"2016-11-15T18:48:46","date_gmt":"2016-11-15T23:48:46","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/hunter-shkolnik-quoted-almtexas-lawyer\/"},"modified":"2016-11-15T18:48:46","modified_gmt":"2016-11-15T23:48:46","slug":"hunter-shkolnik-quoted-almtexas-lawyer","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/en\/article\/hunter-shkolnik-quoted-almtexas-lawyer\/","title":{"rendered":"Hunter Shkolnik Quoted in ALM\/Texas Lawyer About Chemo Drug"},"content":{"rendered":"<p><strong>UPDATE<\/strong>: Hunter Shkolnik has been appointed to the Taxotere Products Liability Litigation Plaintiffs&#8217; Steering Committee by United States District Judge, Kurt D. Engelhardt<\/p>\n<p><a href=\"\/napoli-attorney\/hunter-shkolnik\/\">Partner Hunter Shkolnik<\/a> submitted an application for lead counsel appointment consideration in the Taxotere chemotherapy drug liability multi-district litigation. There has been an unusually large number of plaintiff attorney submissions with more than 40 applications.<\/p>\n<blockquote><p>&#8220;The court should make sure there is appropriate diversity, but should also make sure the people being appointed deserve the position as well,&#8221; said Hunter.<\/p><\/blockquote>\n<p>Taxotere, an injectable concentrate frequently used in chemotherapy to treat breast cancer, has been found to cause permanent hair loss (alopecia). The <a href=\"\/practice-areas\/pharmaceutical-litigation\/taxotere\/\">Taxotere lawsuits<\/a> allege that the chemo drug caused this permanent, disfiguring hair loss and that the patients were never warned about this side effect. Unfortunately there is no antidote for chemo-induced alopecia.<\/p>\n<p>So far approximately 200 cases have been filed by breast cancer patients but it is expected that the number could grow to thousands.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UPDATE: Hunter Shkolnik has been appointed to the Taxotere Products Liability Litigation Plaintiffs&#8217; Steering Committee by United States District Judge, Kurt D. Engelhardt Partner Hunter Shkolnik submitted an application for&#8230;<\/p>\n","protected":false},"author":3,"featured_media":6764,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[858],"class_list":["post-6763","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation","tag-hunter-shkolnik"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/posts\/6763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/comments?post=6763"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/posts\/6763\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/media\/6764"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/media?parent=6763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/categories?post=6763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/tags?post=6763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}